Compound Detail
CHEMBL1221
SULCONAZOLE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1221 |
| Name | SULCONAZOLE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | AFNXATANNDIXLG-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
30
Targets
53
Activities
2
Assay Types
0
PK Parameters
20
Publications
2
Known Names
Molecular Properties
397.8
MW (Da)
6.52
ALogP
3
HBA
0
HBD
17.8
PSA (Ų)
0.47
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1985 |
| Availability | Prescription |
| Chirality | Racemic |
ATC Classification
D01AC09
sulconazole
Level 1: DERMATOLOGICALS
Level 2: ANTIFUNGALS FOR DERMATOLOGICAL USE
Activity Summary
IC50 35 meas. best 7.8
Ki 18 meas. best 7.12
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 7.12 | 7.12 | 75.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 6.85 | 6.85 | 141.0 | 1 |
| Thromboxane-A synthase CHEMBL1835 | IC50 | 6.74 | 6.74 | 183.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 6.26 | 6.26 | 552.0 | 1 |
| Cytochrome P450 1A2 CHEMBL3356 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 6.14 | 6.14 | 717.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 6.14 | 6.14 | 721.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 6.1 | 6.1 | 800.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 6.05 | 6.05 | 885.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 5.98 | 5.98 | 1054.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 5.95 | 5.95 | 1122.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 5.86 | 5.86 | 1371.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 5.84 | 5.84 | 1459.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | Ki | 5.83 | 5.83 | 1485.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 5.82 | 5.82 | 1516.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 5.81 | 5.775 | 1560.0 | 2 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 5.79 | 5.79 | 1636.0 | 1 |
| Substance-K receptor CHEMBL2327 | Ki | 5.78 | 5.78 | 1653.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 5.76 | 5.76 | 1726.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 5.73 | 5.73 | 1873.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 5.72 | 5.72 | 1922.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.7 | 5.66 | 1988.0 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 5.7 | 5.7 | 2010.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 5.69 | 5.69 | 2027.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 5.58 | 5.58 | 2607.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | IC50 | 5.58 | 5.58 | 2628.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 5.55 | 5.55 | 2785.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 5.52 | 5.52 | 3020.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 5.51 | 5.51 | 3104.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 5.47 | 5.47 | 3404.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 5.45 | 5.45 | 3584.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 5.43 | 5.43 | 3675.0 | 1 |
| Tyrosine-protein kinase Fyn CHEMBL1841 | IC50 | 5.43 | 5.43 | 3704.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 5.41 | 5.41 | 3929.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 5.4 | 5.4 | 3958.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 5.39 | 5.39 | 4043.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 5.31 | 5.31 | 4934.0 | 1 |
| Substance-K receptor CHEMBL2327 | IC50 | 5.3 | 5.3 | 4958.0 | 1 |
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | IC50 | 5.19 | 5.19 | 6400.0 | 1 |
| Bile acid receptor CHEMBL2047 | IC50 | 5.16 | 5.16 | 6880.0 | 1 |
| Indoleamine 2,3-dioxygenase 2 CHEMBL2189159 | IC50 | 5.0 | 5.0 | 10100.0 | 1 |
| Beta-lactamase CHEMBL2026 | IC50 | 4.85 | 4.6 | 14000.0 | 4 |
| Malate dehydrogenase, cytoplasmic CHEMBL3560 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Indoleamine 2,3-dioxygenase 1 CHEMBL1075294 | IC50 | 4.53 | 4.53 | 29300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 371 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 14521410 | 10.1021/jm030191r | Beta-lactamase | 4 |
| 25036789 | 10.1016/j.ejmech.2014.06.078 | Indoleamine 2,3-dioxygenase 1 | 4 |
| 13678405 | 10.1021/jm030266r | Beta-lactamase | 3 |
| 17447748 | 10.1021/jm061317y | Beta-lactamase | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 2 |
| 18223646 | 10.1038/nchembio.65 | Eukaryotic peptide chain release factor GTP-binding subunit | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 23688559 | 10.1016/j.bmc.2013.04.069 | Bile acid receptor | 2 |
| 23688559 | 10.1016/j.bmc.2013.04.069 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
Data from ChEMBL 36 via Core Engine